Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study.

Haematologica - 1 Sept 2011

van Dorp Suzanne, Resemann Henrike, te Boome Liane, Pietersma Floor, van Baarle Debbie, Gmelig-Meyling Frits, de Weger Roel, Petersen Eefke, Minnema Monique, Lokhorst Henk, Ebeling Saskia, Beijn Scott J P, Knol Edward F, van Dijk Marijke, Meijer Ellen, Kuball Jürgen

Abstract excerpt

Chronic graft-versus-host disease is the major long-term complication after allogeneic stem cell transplantation with a suboptimal response rate to current treatments. Therefore, clinical efficacy and changes in lymphocyte subsets before and after rituximab treatment were evaluated in a prospecti...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Murine-Derived
Share to Graft vs Host Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematologic Neoplasms

Share to Immunophenotyping

Share to Immunosuppressive Agents

Share to Lymphocyte Depletion

Share to Rituximab

Share to Transplantation, Homologous

Source

Open in PubMed Open full text

Identifiers

PMID: 21546493
DOI: 10.3324/haematol.2011.041814
PMCID: PMC3166111

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21546493-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study.PMID 21546493Read ↗

Chronic graft-versus-host diseaseSemantic proximity Read ↗

Phenotypic evaluation of B-cell subsets after rituximab for treatment of acute renal allograft rejection in pediatric recipients.Semantic proximity Read ↗

The impact of donor-specific anti-HLA antibody levels on primary poor graft function and graft rejection in rituximab desensitized haploidentical stem cell transplantation.Semantic proximity Read ↗

Emerging novel therapies for steroid-refractory acute graft-versus-host disease: recent advances and future directionsSemantic proximity Read ↗

Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients.Semantic proximity Read ↗

Developing role of B cells in the pathogenesis and treatment of chronic GVHDSemantic proximity Read ↗

Graft-versus-host diseaseSemantic proximity Read ↗

Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.Semantic proximity Read ↗

The role of B cells in the pathogenesis of chronic graft-versus-host diseaseSemantic proximity Read ↗

Chronic graft-versus-host disease: A prospective cohort studySemantic proximity Read ↗

Rituximab resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.